Cowen and Company’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Cowen and Company’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,999	Closed	-$3.48M	–	764
2023 Q4	$3.48M	Buy	+10,999	New	+$2.14M	0.23%	76

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Cowen and Company's KRTX Position: Q1 2024 in Review

Cowen and Company sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 10,999 shares — an estimated $3.48M sold.

Cowen and Company first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $3.48M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Cowen and Company reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Cowen and Company sold 10,999 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.48M.
Cowen and Company first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Cowen and Company's Karuna Therapeutics, Inc. Common Stock position peaked at $3.48M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.